Delivery Order SPE2DB22D1103-SPE2DB24FTMC3
Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,503.91 and an ultimate completion date of March 12, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $2,584.78 and a performance period through April 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM. The contract has a firm fixed price of $1,025.47 and a completion date of July 14, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract has a ceiling value of $2,422.98 and is a firm fixed-price agreement with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.08, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 23, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluticasone Prop HFA 220 MCG 12GM medical products. The contract has a ceiling value of $1,778.18 and a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has a ceiling value of $1,949.87 and is a firm-fixed-price contract type. The period of performance runs through June 26, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM medical product. The $3,990.40 firm fixed price contract has a completion date of November 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,103.13 firm fixed-price contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a performance period ending on May 21, 2025. This order is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,069.92, is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order and is not designated as a set-aside. It has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTMC3Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,586.96 and runs through June 13, 2024. It is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 5/17/25, 9:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/12/24 |